NKG2D in NK and T cell-mediated immunity

被引：93
|
作者：
Ogasawara, K
Lanier, LL
机构：
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA
[3] Int Med Ctr Japan, Dept Intractable Dis, Div Clin Immunol, Res Inst,Shinjuku Ku, Tokyo, Japan
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2005年 / 25卷 / 06期
基金：
美国国家卫生研究院;
关键词：
NK cells; NKG2D; DAP10; RAE-1; MICA; autoimmunity; bone marrow transplantation; T cell;
D O I：
10.1007/s10875-005-8786-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
One of the best characterized NK cell receptors is NKG2D, a highly conserved C-type lectin-like membrane glycoprotein expressed on essentially all NK cells, as well as on gamma delta-TcR+ T cells and alpha beta-TcR+ CD8(+) T cells, in humans and mice. Here we review recent studies implicating NKG2D in T cell and NK cell-mediated immunity to viruses and tumors, and its potential role in autoimmune diseases and allogeneic bone marrow transplantation.
引用
收藏
页码：534 / 540
页数：7
相关论文
共 50 条
  • [31] Correction: Corrigendum: Fas ligand–mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity
    Veronika Groh
    Kimberly Smythe
    Zhengpeng Dai
    Thomas Spies
    Nature Immunology, 2006, 7 : 1004 - 1004
  • [32] CD8+T cell-mediated tumor specific induction of the NKG2D ligands to trigger NKG2D-dependent tumor cell death in vivo
    Hu, Jiemiao
    Xia, Xueqing
    Kleinerman, Eugenie S.
    Li, Shulin
    CANCER RESEARCH, 2015, 75
  • [33] NKG2D ligands in tumor immunity
    Nausch, N.
    Cerwenka, A.
    ONCOGENE, 2008, 27 (45) : 5944 - 5958
  • [34] NKG2D in innate and adaptive immunity
    Lanier, LL
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION X: INNATE IMMUNITY, 2005, 560 : 51 - 56
  • [35] NKG2D ligands in tumor immunity
    N Nausch
    A Cerwenka
    Oncogene, 2008, 27 : 5944 - 5958
  • [36] NKG2D is the main receptor involved in NK cell activation against NKG2D ligand-positive melanoma cell lines
    Morgado, S.
    Sanchez-Correa, B.
    Casado, J. G.
    Gordillo, J.
    Gayoso, I.
    Duran, M. E.
    Solana, R.
    Tarazona, R.
    IMMUNOLOGY, 2012, 137 : 242 - 242
  • [37] CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells
    Peipp, M.
    Wesch, D.
    Oberg, H. -H.
    Lutz, S.
    Muskulus, A.
    van de Winkel, J. G. J.
    Parren, P. W. H. I.
    Burger, R.
    Humpe, A.
    Kabelitz, D.
    Gramatzki, M.
    Kellner, C.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 196 - 206
  • [38] The CD8+ T cell-mediated protection against tuberculosis is dependent on IL-15 and NKG2D
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 437 - 437
  • [39] Involvement of an NKG2D Ligand H60c in Epidermal Dendritic T Cell-Mediated Wound Repair
    Yoshida, Shigeru
    Mohamed, Rania Hassan
    Kajikawa, Mizuho
    Koizumi, Jun
    Tanaka, Minami
    Fugo, Kazunori
    Otsuka, Noriyuki
    Maenaka, Katsumi
    Yagita, Hideo
    Chiba, Hitoshi
    Kasahara, Masanori
    JOURNAL OF IMMUNOLOGY, 2012, 188 (08): : 3972 - 3979
  • [40] Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity
    Yang, Fengqiang
    Shao, Yang
    Yang, Fengping
    Liu, Ming
    Huang, Jianhua
    Zhu, Kai
    Guo, Changcheng
    Luo, Jun
    Li, Wei
    Yang, Bin
    Shi, Jumei
    Zheng, Junhua
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (02) : 323 - 331
12345